Egyptian study reveals hidden breast cancer subtype
NCT ID NCT06188494
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study reviewed medical records of 405 people in Egypt with advanced HER2-negative breast cancer to find out how many actually have a subtype called HER2-low. Researchers looked at past test results to estimate the prevalence. The goal is to better understand who might be eligible for newer treatments targeting HER2-low cancers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better identify patients who might benefit from newer targeted therapies for HER2-low breast cancer.
What could go wrong
This is an observational study that only looks back at existing data, so it cannot prove any treatment works. The results may not apply to other populations or testing methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandria, Egypt
-
Research Site
Asyut, Egypt
-
Research Site
Cairo, Egypt
-
Research Site
Gharbia, Egypt
-
Research Site
Giza, Egypt
-
Research Site
Luxor, Egypt
-
Research Site
Sohag, Egypt